Using Rivaroxaban to treat radial artery occlusion after heart procedures

Is this trial a fit for you?

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This study aims to evaluate the effectiveness of Rivaroxaban in treating radial artery occlusion (RAO) following cardiac catheterization procedures, including angiography and percutaneous coronary intervention (PCI). It is a prospective, single-center, randomized controlled trial where patients with RAO will be divided into two groups: one receiving Rivaroxaban and the other receiving no anticoagulation. The primary goal is to assess the patency rates of the radial artery at four weeks post-procedure, while secondary objectives include comparing complications at the access site and systemic complications. RAO will be diagnosed using radial artery ultrasound within 24 hours after the procedure.

Why it matters

Who can join: the full rules

Inclusion Criteria:

1. Patients (both male and female) undergoing a coronary catheterization procedure (both angiography and PCI) through the transradial access and having successfully received at least one radial artery sheath of any size at the end of the procedure
2. Radial artery occlusion confirmed by ultrasound (2D, Doppler, colour)

Exclusion Criteria:

1. Age \< 18 years
2. Unable to provide informed written consent
3. Any contraindication to receive Rivaroxaban

Where it's running

• AHEPA University Hospital
  Thessaloniki, Greece Recruiting

Study contacts

• Study coordinator: Matthaios Didagelos, MD, MSc, PhD
• Email: manthosdid@yahoo.gr
• Phone: 2310994830

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

• Radial and Ulnar Access in Vascular Interventions Registry

  This registry tests how often radial or ulnar artery access is used and what happens afterward in routine vascular procedures.

  Recruiting Mersin Medicalpark Hastanesi · Mersin, Mezitli · NCT07614386

• Using the ulnar artery when the same-arm radial artery is blocked for heart angiography or angioplasty

  This study will try using the ulnar artery in the same arm with a blocked radial artery to see if it's safe and how it affects hand strength, feeling, and everyday hand use in adults having coronary angiography or angioplasty.

  Recruiting at 2 sites National and Kapodistrian University of Athens · Athens and 1 other locations · NCT07380399

• Systematic versus selective heparin use to prevent radial artery occlusion after catheterization

  This test compares giving heparin to all patients versus only to selected patients to see which approach better prevents radial artery blockage after diagnostic transradial catheterization.

  Recruiting Laval University · Québec, Quebec · NCT06981624

• Best timing for heparin during radial-access coronary procedures

  This research will test whether giving heparin before inserting the radial sheath instead of after lowers the chance of radial artery occlusion in adults having radial-access coronary angiography or PCI.

  Recruiting University Hospital, Strasbourg, France · Strasbourg, Bas-Rhin · NCT06890312

• Using a new device to prevent radial artery occlusion after catheterization

  This study is testing a new band to see if it can help prevent blockage in the wrist artery after heart procedures, making it safer and more comfortable for patients.

  Recruiting Laval University · Chicoutimi, Quebec and 4 other locations · NCT04933136

• How preoperative QFR might affect graft outcomes after CABG

  This study looks to see if measuring Quantitative Flow Reserve before surgery helps improve graft results and reduce heart- and brain-related events in people having coronary artery bypass grafting.

  Recruiting Peking University Third Hospital · Beijing, Beijing Municipality · NCT07669987

How to take part

1. Review the eligibility criteria above with your treating physician.
2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.